STUDY OF A REDUCED-TOXICITY MYELOABLATIVE CONDITIONING REGIMEN USING FLUDARABINE AND FULL DOSES OF INTRAVENOUS BUSULFAN IN PEDIATRIC PATIENTS NOT ELIGIBLE FOR STANDARD MYELOABLATIVE CONDITIONING REGIMENS: